Literature DB >> 6124041

Nerve growth factor attenuates neurotoxic effects of taxol on spinal cord-ganglion explants from fetal mice.

E R Peterson, S M Crain.   

Abstract

Most neurons in organotypic cultures of dorsal root ganglia from 13-day-old fetal mice require high concentrations of nerve growth factor for survival during the first week after explanation. These nerve growth factor-enhanced sensory neurons mature and innervate the dorsal regions of attached spinal cord tissue even after the removal of exogenous growth factor after 4 days. In cultures exposed for 4 days to nerve growth factor and taxol (a plant alkaloid that promotes the assembly of microtubules) and returned to medium without growth factor, greater than 95 percent of the ganglionic neurons degenerated and the spinal cord tissues were reduced almost to monolayers. In contrast, when the recovery medium was supplemented with nerve growth factor, the ganglionic neurons and dorsal (but not ventral) cord tissue survived remarkably well. Dorsal cord neurons do not normally require an input from dorsal root ganglia for long-term maintenance in vitro, but during and after taxol exposure they become dependent for survival and recovery on the presence of neurite projections from nerve growth-factor-enhanced dorsal root ganglia.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6124041     DOI: 10.1126/science.6124041

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  13 in total

1.  The protective effect of nerve growth factor in nerve tissue cultures exposed to diphtheria toxin.

Authors:  N I Chalisova; G N Akoev; V A Pennijainen
Journal:  Neurosci Behav Physiol       Date:  1999 Jul-Aug

2.  P2Y(1) purinoceptor-mediated Ca(2+) signaling and Ca(2+) wave propagation in dorsal spinal cord astrocytes.

Authors:  S R Fam; C J Gallagher; M W Salter
Journal:  J Neurosci       Date:  2000-04-15       Impact factor: 6.167

3.  Microtubule reorganization is obligatory for growth cone turning.

Authors:  T Williamson; P R Gordon-Weeks; M Schachner; J Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-24       Impact factor: 11.205

4.  Estrogen facilitates spinal cord synaptic transmission via membrane-bound estrogen receptors: implications for pain hypersensitivity.

Authors:  Yan Zhang; Xiao Xiao; Xiao-Meng Zhang; Zhi-Qi Zhao; Yu-Qiu Zhang
Journal:  J Biol Chem       Date:  2012-08-06       Impact factor: 5.157

5.  P2Y13 receptor-mediated rapid increase in intracellular calcium induced by ADP in cultured dorsal spinal cord microglia.

Authors:  Junwei Zeng; Gaoxia Wang; Xiaohong Liu; Chunmei Wang; Hong Tian; Aidong Liu; Huan Jin; Xiaomei Luo; Yuanshou Chen
Journal:  Neurochem Res       Date:  2014-09-04       Impact factor: 3.996

Review 6.  Growth factors: potential therapeutic applications in neurology.

Authors:  J Drago; T J Kilpatrick; S A Koblar; P S Talman
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-12       Impact factor: 10.154

7.  Anti-cancer drug induced neurotoxicity and identification of Rho pathway signaling modulators as potential neuroprotectants.

Authors:  Sarah E James; Hubert Burden; Russell Burgess; Youmei Xie; Tao Yang; Stephen M Massa; Frank M Longo; Qun Lu
Journal:  Neurotoxicology       Date:  2008-04-26       Impact factor: 4.294

8.  Peripheral neuropathy induced by paclitaxel: recent insights and future perspectives.

Authors:  Charity D Scripture; William D Figg; Alex Sparreboom
Journal:  Curr Neuropharmacol       Date:  2006-04       Impact factor: 7.363

9.  Nerve growth factor regulates the action potential duration of mature sensory neurons.

Authors:  A Chalazonitis; E R Peterson; S M Crain
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

10.  Nerve growth factor alters microtubule targeting agent-induced neurotransmitter release but not MTA-induced neurite retraction in sensory neurons.

Authors:  Sherry K Pittman; Neilia G Gracias; Jill C Fehrenbacher
Journal:  Exp Neurol       Date:  2016-02-13       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.